Top News
Genetic Overlap Between Autoimmune Disease and NHL Not Supported by Genome-Wide Association Study
Some Discrepancies Seen Between Real-Life and Guideline-Recommended Care of Chronic Myeloid Leukemia
Premedication With Dexamethasone May Prevent Pemetrexed-Associated Skin Rash
New Treatment Option Approved for Patients With Myelofibrosis
Robotic, Open Cystectomy for Bladder Cancer Offer Comparable Outcomes
Adding Bevacizumab to Erlotinib Fails to Improve PFS in EGFR-Mutant NSCLC
Rozlytrek, a Tumor Agnostic Therapy, Receives FDA Approval
Burden of Obesity-Associated Cancers Shifted to Younger Age Groups
Cost Burden of Disease Progression High in Multiple Myeloma
EDITORIAL ADVISORY BOARD
E. David Crawford, MD
Jeffrey M. Farma, MD
Featured
-
Personalized Cancer Vaccine NEO-PV-01 Shows Promise in Three Types of Advanced Cancer
Early results from a clinical trial of personalized cancer vaccine NEO-PV-01 in 3 types of advanced cancer have shown promise and no significant toxicity issues. -
Looking at Survival Differently in Patients With Metastatic Kidney Cancer
Conditional survival may more accurately assess prognosis than traditional survival for patients with metastatic kidney cancer, but the metric is not without its caveats. -
Female Childhood Cancer Survivors Are at Increased Risk for Breast Cancer Due to Anthracycline Treatment
Survivors of childhood cancers who were treated with anthracyclines are at increased risk for developing breast cancer. -
A Tool to Select Candidates for Allogeneic Hematopoietic Cell Transplant in CLL
As oncologists welcome new chronic lymphocytic leukemia treatments, one researcher creates a scoring system to make the case for transplants. -
New Trial Attempts to Make Genetic Counseling and Testing More Accessible
The researchers wrote that “genetic counseling must be further explored to find an optimal balance of clinical quality with increased access and financial sustainability.” -
T-Cell Cryopreservation for Use in Future Cancer Treatment: Hot or Hype?
Can healthy immune cells from a patient be frozen and used in the future to make adoptive cell therapies in the event of a cancer diagnosis?
More Features
Real-World Data in the Era of Precision Medicine for Lymphoid Malignancies
The use of real-world data shows promise in guiding the development of management strategies for lymphoid malignancies.
Metastatic Colorectal Cancer Treatment Options: New BRAF V600E Data
The combination of ENCO and BINI had greater antitumor activity against mCRC cells with the BRAF V600E mutation.
Prostate Cancer and Androgen Deprivation Therapy: Is There a Link to Dementia?
Patients treated with ADT for prostate cancer had a higher hazard ratio for developing Alzheimer disease than those who did not receive this therapy.
Axi-Cel Moves Toward the First-Line Setting for High-Risk Large B-Cell Lymphoma
Are patients who have received fewer prior medications better candidates for the receipt of CAR-T therapies?
The Cost of Cancer and How Health Care Providers Can Help Mitigate Financial Toxicity
A close-up look at the cost of cancer care, current legislative actions, and tools clinicians can use to help ease patients’ financial burden.
